Plasma drug levels, genotypic resistance, and virological response to a nelfinavir plus saquinavir-containing regimen.
about
Association of saquinavir plasma concentrations with side effects but not with antiretroviral outcome in patients infected with protease inhibitor-susceptible human immunodeficiency virus type 1Pharmacokinetics of indinavir and nelfinavir in treatment-naive, human immunodeficiency virus-infected subjectsA review of nelfinavir for the treatment of HIV infection.Therapeutic drug monitoring in highly active antiretroviral therapy.Therapeutic drug monitoring of antiretroviral drugs in HIV-infected patients.
P2860
Plasma drug levels, genotypic resistance, and virological response to a nelfinavir plus saquinavir-containing regimen.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Plasma drug levels, genotypic ...... saquinavir-containing regimen.
@en
Plasma drug levels, genotypic ...... saquinavir-containing regimen.
@nl
type
label
Plasma drug levels, genotypic ...... saquinavir-containing regimen.
@en
Plasma drug levels, genotypic ...... saquinavir-containing regimen.
@nl
prefLabel
Plasma drug levels, genotypic ...... saquinavir-containing regimen.
@en
Plasma drug levels, genotypic ...... saquinavir-containing regimen.
@nl
P2093
P1433
P1476
Plasma drug levels, genotypic ...... saquinavir-containing regimen.
@en
P2093
Ana Moreno
Antonio Antela
Fernando Dronda
Jose L Casado
Kurt Hertogs
María J Perez-Elías
NELSANE study
Pascale Dehertogh
Santiago Moreno
P356
10.1097/00002030-200201040-00007
P407
P577
2002-01-01T00:00:00Z